Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$504M |
| 2 |
Cigna
CI
|
+$469M |
| 3 |
Intuitive Surgical
ISRG
|
+$392M |
| 4 |
Procter & Gamble
PG
|
+$387M |
| 5 |
Parker-Hannifin
PH
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$357M |
| 2 |
Adeia
ADEA
|
+$356M |
| 3 |
Target
TGT
|
+$346M |
| 4 |
Salesforce
CRM
|
+$344M |
| 5 |
Eli Lilly
LLY
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 12.51% |
| 3 | Financials | 11.68% |
| 4 | Industrials | 8.82% |
| 5 | Consumer Discretionary | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RC
2176
Ready Capital
RC
$258M
| $5.39M | ﹤0.01% |
483,423
-49,523
| -9% | -$596K |
|
2177
Anika Therapeutics
ANIK
$258M
| $5.38M | ﹤0.01% |
181,943
-9,417
| -5% | -$268K |
|
2178
Unitil
UTL
$970M
| $5.38M | ﹤0.01% |
104,666
-6,855
| -6% | -$349K |
|
2179
Kiniksa Pharmaceuticals
KNSA
$5.8B
| $5.34M | ﹤0.01% |
356,616
-17,374
| -5% | -$253K |
|
|
AVTA
2180
DELISTED
Avantax, Inc. Common Stock
AVTA
| $5.34M | ﹤0.01% |
209,064
-7,164
| -3% | -$164K |
|
2181
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.37B
| $5.33M | ﹤0.01% |
445,261
-27,353
| -6% | -$298K |
|
|
NEWR
2182
DELISTED
New Relic, Inc.
NEWR
| $5.32M | ﹤0.01% |
94,272
-7,798
| -8% | -$441K |
|
2183
Nordson
NDSN
$16.6B
| $5.32M | ﹤0.01% |
22,359
+1,841
| +9% | +$420K |
|
|
UNIT
2184
Uniti Group
UNIT
$2.36B
| $5.3M | ﹤0.01% |
959,360
-26,050
| -3% | -$179K |
|
|
AAMI
2185
Acadian Asset Management
AAMI
$3.08B
| $5.3M | ﹤0.01% |
257,324
-7,843
| -3% | -$148K |
|
2186
Helen of Troy
HELE
$644M
| $5.29M | ﹤0.01% |
47,680
-721
| -1% | -$70.2K |
|
2187
Valens Semiconductor
VLN
$170M
| $5.28M | ﹤0.01% |
983,588
-9,100
| -0.9% | -$38.5K |
|
2188
John Wiley & Sons Class A
WLY
$2.65B
| $5.26M | ﹤0.01% |
131,381
-4,821
| -4% | -$202K |
|
2189
CRA International
CRAI
$1.16B
| $5.26M | ﹤0.01% |
42,943
-3,316
| -7% | -$365K |
|
2190
Invesco Water Resources ETF
PHO
$2.01B
| $5.26M | ﹤0.01% |
96,647
+36,942
| +62% | +$1.86M |
|
2191
Global X Copper Miners ETF NEW
COPX
$7.29B
| $5.25M | ﹤0.01% |
148,069
+54,821
| +59% | +$1.8M |
|
|
JHG
2192
DELISTED
Janus Henderson
JHG
| $5.25M | ﹤0.01% |
223,072
-1,987
| -0.9% | -$46.6K |
|
2193
Douglas Emmett
DEI
$1.98B
| $5.24M | ﹤0.01% |
333,969
+43,311
| +15% | +$721K |
|
2194
Bio-Rad Laboratories Class A
BIO
$8.71B
| $5.24M | ﹤0.01% |
12,366
+868
| +8% | +$350K |
|
2195
QCR Holdings
QCRH
$1.69B
| $5.24M | ﹤0.01% |
105,541
+16,359
| +18% | +$843K |
|
2196
Oil-Dri
ODC
$1.44B
| $5.22M | ﹤0.01% |
311,476
+17,922
| +6% | +$270K |
|
2197
Deluxe
DLX
$1.18B
| $5.22M | ﹤0.01% |
307,291
+5,355
| +2% | +$95.3K |
|
2198
VictoryShares US Large Cap High Div Volatility Wtd ETF
CDL
$401M
| $5.21M | ﹤0.01% |
88,499
+44,056
| +99% | +$2.55M |
|
2199
Wendy's
WEN
$1.4B
| $5.2M | ﹤0.01% |
229,984
-17,186
| -7% | -$367K |
|
2200
PJT Partners
PJT
$4.3B
| $5.2M | ﹤0.01% |
70,568
+12,555
| +22% | +$941K |
|
Similar funds
Ameriprise's Q4 2022 Portfolio in Review
As of Q4 2022, Ameriprise held 4,135 positions worth $292B, up 7.9% from $270B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Ameriprise's Q4 2022 filing shows 152 new, 1,522 increased, 2,111 reduced and 185 closed positions. Its largest new stake was Abcam PLC: 5,014,378 shares worth $78M. The largest sale was CVS Health, an estimated $357M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q4 2022 buy was Abcam PLC: 5,014,378 shares worth $78M.
- Ameriprise added most to Prologis in Q4 2022, an estimated $504M increase.
- Ameriprise's biggest Q4 2022 reduction was CVS Health, cutting an estimated $357M.
- Ameriprise fully exited Duke Realty Corp. in Q4 2022, selling an estimated $166M.
- Ameriprise's ten largest holdings make up 13% of its $292B portfolio in Q4 2022.
- Ameriprise opened 152 new positions and closed 185 in Q4 2022.
- Ameriprise's portfolio value rose 7.9% quarter-over-quarter to $292B.
Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.